Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer.

Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Abstract Text:

    makito okamotoMakito Okamoto,hiroomi takahashiHiroomi Takahashi,kazuo yaoKazuo Yao,katsuhide inagiKatsuhide Inagi,meijin nakayamaMeijin Nakayama,hiromi nagaiHiromi Nagai,

    Eighty-eight patients with hypopharyngeal cancer who received chemoradiotherapy as the primary treatment between 1979 and 1997 were investigated. Forty-six patients who received surgery as the primary treatment were analyzed as a control group. There were no statistically significant differences regarding TN classification, tumor stage, tumor site, age or sex between the radiation and surgery groups. The 5-year cumulative survival rate of primary chemoradiotherapy was 47% and this did not differ significantly from that for the primary surgery group. The larynx was preserved in 74% of cases in the primary chemoradiotherapy group, a far better preservation rate than that in the surgery group. After primary chemoradiotherapy, complete remission (CR) was observed in 59% of cases and the average period of CR was 38 months. Among patients with residual tumor, a salvage operation was employed in 31 cases, 13 patients refused to receive surgery and 8 were inoperable. A salvage operation was performed in 35% of all cases and the 5-year cumulative survival rate was 50%. Based on the 5-year survival, primary CR, salvage and laryngeal preservation rates, we conclude that chemoradiotherapy is a good primary treatment for hypopharyngeal cancer.

    Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Publishing Authors By Initials

    m okamotoM Okamoto,h takahashiH Takahashi,k yaoK Yao,k inagiK Inagi,m nakayamaM Nakayama,h nagaiH Nagai,

    For similar heterocyclic compounds: heterocyclic compounds, 1-ring: pyrimidines: pyrimidinones: uracil research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: pyrimidines: pyrimidinones: uracil research

    PUBMED ID PMID:

    MEDLINE DATE:

    Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Acta oto-laryngologica. Supplementum

    VOLUME:

    Page Numbers: 11-4

    Journal Abbreviation:

    ISSN: 0365-5237

    DAY: 13

    MONTH: 02

    YEAR: 2002

    Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370355

    Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Keywords Mesh Terms:

    KEYWORDS: Uracil

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer. Information

    Substance Name: Uracil

    Registry Number: 66-22-8

    Grant and Affiliation Information for Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer.

    AFFILIATION: Department of Otorhinolaryngology, School of Medicine, Kitasato University, Kanagawa, Japan. okamotom@med.kitasato-u.ac.jp

    Country: Norway

    Norway Research PublicationNorway Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Acta Otolaryngol Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News